COVID-19: DCGI approved NovaLead Pharma to conduct clinical
The Drugs Controller General of India (DCGI) has granted approval to NovaLead Pharma for conducting of phase III clinical trials for its repurposed drug discovery for treatemnt of moderate COVID-19…
CDSCO observed shortage of 15 drugs
A letter has been issued by the Central Drugs Standard Control Organisation (CDSCO) to all drug manufacturers associations giving an information about the low supply of 15 essential drugs which…
Director of Himachal Health Services arrested in ‘corruption case’
Dr Ajay Gupta, The Director of Himachal Pradesh Health Services, was arrested by the state Vigilance and Anti-Corruption Bureau allegedly in a corruption case on the basis of audio recording.…
Aster DM Healthcare to groom people for New Normal post COVID
Dubai/ New Delhi: Aster DM Healthcare – one of the largest private, integrated healthcare service providers across the GCC and an emerging player in India has launched ‘Our New Earth’,…
Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease approved by DCGI
May 20, 2020: Drugs Controller General of India (DCGI) has approved Nintedanib by Boehringer Ingelheim (India) in treating systemic sclerosis-associated interstitial lung disease (SSc-ILD) in adults. Earlier on 3rd March,…
59 product licenses to 37 new comapines to manufacture azithromycin approved by Gujarat FDCA
The Gujarat Food and Drug Control Administration (FDCA) has approved 59 product licenses to 37 manufacturers for production of azithromycin as a basic treatment for Covid-19 patients. Hydroxychloroquine (HCQ) in…
Ayurvedic Rasayanas hold a great Promise in Battle against COVID 19
New Delhi: What Maharishi Charaka — the father of Ayurveda system of medicine mentioned 2000 years ago in ‘Charak Samhita’, “Rasayana treatment is also an answer to epidemics”, has now…
NPPA: Six paracetamol API manufacturers to export half of monthly production
The National Pharmaceutical Pricing Authority (NPPA) has grantedt nod to six major manufacturers for exporting 50 per cent of their monthly operating capacity of paracetamol active pharmaceutical ingredient (API) subject…
Covid-19: ICMR revised strategy for testing in country
On Monday, The Indian Council of Medical Research (ICMR) has revised the strategy for testing coronavirus disease as the number of infected people crossed 1,00,000 mark today The updated strategy…
Amid Lockdown 1st Patients’ Rights eConclave held
New Delhi: A unique of its kind 1steConclave around ‘Patients’ Rights’ was held amid the hue and cry of COVID-19 panic. It addressed almost all the issues of ‘Patients’ Rights.’…
